Coenzyme Q10 in neurodegenerative disorders: Potential benefit of CoQ10 supplementation for multiple system atrophy

doi:10.5316/wjn.v4.i1.1

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9976)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

604

WORD

365

HTML

6667

Figures (1-1)

256

Tables (1-1)

240

Sum=8132

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1019

Download

825

Sum=1844

Mar 28, 2014 (publication date) through Jan 6, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Neurology

ISSN

2218-6212

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Neurol. Mar 28, 2014; 4(1): 1-6
Published online Mar 28, 2014. doi: 10.5316/wjn.v4.i1.1

Full Size Figure Download Figure

Figure 1 Coenzyme Q10 biosynthesis pathway. Enzyme and human gene symbols are shown in italics. HMG-CoA: 3-hydroxy-3-methylglutaryl coenzyme A; PDSS: Prenyldiphosphate synthase subunit; PP: Pyrophosphate; PHB: Para-hydroxy-benzoate; CoQ10: Coenzyme Q10; CABC: Chaperone-activity of bc1.

Citation: Takahashi H, Shimoda K. Coenzyme Q10 in neurodegenerative disorders: Potential benefit of CoQ10 supplementation for multiple system atrophy. World J Neurol 2014; 4(1): 1-6
URL: https://www.wjgnet.com/2218-6212/full/v4/i1/1.htm
DOI: https://dx.doi.org/10.5316/wjn.v4.i1.1